CARTRIDGE-BASED NUCLEIC ACID AMPLIFICATION TEST, AN IMPORTANT DIAGNOSTIC TOOL FOR TUBERCULOSIS BOTH PULMONARY AND EXTRA-PULMONARY TUBERCULOSIS

Authors

  • Girija Shankar Udgata Department of Pulmonary Medicine, BBMCH, Balangir, Odisha, India.
  • SRIKANTA DASH Department of Pulmonary Medicine, BBMCH, Balangir, Odisha, India.
  • SASMITA MEHER Department of Pulmonary Medicine, BBMCH, Balangir, Odisha, India.
  • ANANYA UDGATA Department of Pharmacology, BBMCH, Balangir, Odisha, India.
  • HOTA S Department of Ophthalmology, BBMCH, Balangir, Odisha, India.

DOI:

https://doi.org/10.22159/ajpcr.2023.v16i7.48398

Keywords:

Tuberculosis, Ziehl-Neelsen stain, Cartridge-based nucleic acid amplification test, Pulmonary and extra pulmonary tuberculosis

Abstract

Objective: Tuberculosis (TB) is severe infectious disease caused by Mycobacterium tuberculosis and imposes significant morbidity and mortality. Early diagnosis of active TB forms pulmonary and extrapulmonary is very important and the diagnostic methods such as culture test and Ziehl-Neelsen (ZN) stain displayed low diagnostic accuracy. Cartridge-based nucleic acid amplification test (CBNAAT) is widely used for the diagnosis of TB with good accuracy rate. Hence, the current study was commenced to assess the diagnostic usefulness of CBNAAT for the diagnosis of mycobacterium TB (MTB) and compared with ZN staining.

Methods: This was a prospective study conducted on 250 sputum samples of pulmonary TB (new cases) and also patients who were receiving the treatment for TB. 5 mL of sputum sample including CSF, pericardial or ascitic fluid, pus, or lymph nodes aspirates were collected and subjected to ZN staining and CBNAAT.

Results: Mean age observed was 48.12±8.76 years. 30 (12%) showed smear positive and 220 (88%) were smear negative for ZN staining. Further, samples have been subjected to CBNAAT showed 60 (24%) MTB positive, and 190 (74%) showed MTB negative. CBNAAT showed sensitivity and specificity of 91.5% and 89%. Out of 60 positives for MTB by CBNAAT, MTB has been identified in 28 patients.

Conclusion: CBNAAT is a great tool in the early diagnosis of pulmonary and extrapulmonary TB.

Downloads

Download data is not yet available.

References

WHO. Global Tuberculosis Report 2019. Switzerland: World Health Organization; 2020.

Lee JY. Diagnosis and treatment of extrapulmonary tuberculosis. Tuberc Respir Dis (Seoul) 2015;78:47-55. doi: 10.4046/trd.2015.78.2.47, PMID 25861336

Nagaraja SB, Thekkur P, Satyanarayana S, Tharyan P, Sagili KD, Tonsing J, et al. Active case finding for tuberculosis in India: A syntheses of activities and outcomes reported by the national tuberculosis elimination programme. Trop Med Infect Dis 2021;6:206. doi: 10.3390/tropicalmed6040206, PMID 34941662

Sharma SK, Mohan A. Tuberculosis: From an incurable scourge to a curable disease-journey over a millennium. Indian J Med Res 2013;137:455-93. PMID 23640554

Daniel TM. Rapid diagnosis of tuberculosis: Laboratory techniques applicable in developing countries. Rev Infect Dis 1989;11;(Suppl 2):S471-8. doi: 10.1093/clinids/11.supplement_2.s471, PMID 2652258

Savić B, Sjöbring U, Alugupalli S, Larsson L, Miörner H. Evaluation of polymerase chain reaction, tuberculostearic acid analysis, and direct microscopy for the detection of Mycobacterium tuberculosis in sputum. J Infect Dis 1992;166:1177-80. doi: 10.1093/infdis/166.5.1177, PMID 1402031

Sachdeva K, Shrivastava T. CBNAAT: A boon for early diagnosis of tuberculosis-head and neck. Indian J Otolaryngol Head Neck Surg 2018;70:572-7. doi: 10.1007/s12070-018-1364-x, PMID 30464918

Comas I, Gagneux S. A role for systems epidemiology in tuberculosis research. Trends Microbiol 2011;19:492-500. doi: 10.1016/j. tim.2011.07.002, PMID 21831640

Qian X, Nguyen DT, Lyu J, Albers AE, Bi X, Graviss EA. Risk factors for extrapulmonary dissemination of tuberculosis and associated mortality during treatment for extrapulmonary tuberculosis. Emerg Microbes Infect 2018;7:102. doi: 10.1038/s41426-018-0106-1, PMID 29872046

Azad KA, Chowdhury T. Extrapulmonary tuberculosis (Eptb): An overview. Bangladesh J Med 2022;33:130-7. doi: 10.3329/bjm. v33i2.59285

Wingfield T, MacPherson P, Cleary P, Ormerod LP. High prevalence of TB disease in contacts of adults with extrapulmonary TB. Thorax 2018;73:785-7. doi: 10.1136/thoraxjnl-2017-210202, PMID 29146867

Lönnroth K, Raviglione M. The WHO’s new end tb strategy in the post- 2015 era of the sustainable development goals. Trans R Soc Trop Med Hyg 2016;110:148-50. doi: 10.1093/trstmh/trv108, PMID 26884490

Zeka AN, Tasbakan S, Cavusoglu C. Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and extrapulmonary specimens. J Clin Microbiol 2011;49:4138-41. doi: 10.1128/JCM.05434-11, PMID 21956978

Mukherjee A, Saha I, Sarkar A, Chowdhury R. Gender differences in notification rates, clinical forms and treatment outcome of tuberculosis patients under the RNTCP. Lung India 2012;29:120-2. doi: 10.4103/0970-2113.95302, PMID 22628924

Borgdorff MW, Nagelkerke NJ, Dye C, Nunn P. Gender and tuberculosis: A comparison of prevalence surveys with notification data to explore sex differences in case detection. Int J Tuberc Lung Dis 2000;4:123-32. PMID 10694090

Chan-Yeung M, Noertjojo K, Chan SL, Tam CM. Sex differences in tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2002;6:11-8. PMID 11931395

Tortoli E, Russo C, Piersimoni C, Mazzola E, Dal Monte P, Pascarella M, et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur Respir J 2012;40:442-7. doi: 10.1183/09031936.00176311, PMID 22241741

Scott LE, Beylis N, Nicol M, Nkuna G, Molapo S, Berrie L, et al. Diagnostic accuracy of Xpert MTB/RIF for extrapulmonary tuberculosis specimens: Establishing a laboratory testing algorithm for South Africa. J Clin Microbiol 2014;52:1818-23. doi: 10.1128/ JCM.03553-13, PMID 24622091

Hillemann D, Rüsch-Gerdes S, Boehme C, Richter E. Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. J Clin Microbiol 2011;49:1202-5. doi: 10.1128/ JCM.02268-10, PMID 21270230

Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, Rodrigues C. Xpert MTB/RIF: A new pillar in diagnosis of extrapulmonary tuberculosis? J Clin Microbiol 2011;49:2540-5. doi: 10.1128/JCM.02319-10, PMID 21593262

Suzana S, Ninan MM, Gowri M, Venkatesh K, Rupali P, Michael JS. Xpert MTB/Rif for the diagnosis of extrapulmonary tuberculosis-an experience from a tertiary care centre in South India. Trop Med Int Health 2016;21:385-92. doi: 10.1111/tmi.12655, PMID 26671654

Krishna V, Gopalakrishnan R, Tarigopula A, Panchatcharam SN, Dorairajan SK, Venkatasubramanian R. Utility of Xpert® MTB/RIF in the diagnosis of extrapulmonary tuberculosis. Indian J Med Microbiol 2019;37:448-9. doi: 10.4103/ijmm.IJMM_19_149, PMID 32003351

Published

07-07-2023

How to Cite

Udgata, G. S., S. DASH, S. MEHER, A. UDGATA, and H. S. “CARTRIDGE-BASED NUCLEIC ACID AMPLIFICATION TEST, AN IMPORTANT DIAGNOSTIC TOOL FOR TUBERCULOSIS BOTH PULMONARY AND EXTRA-PULMONARY TUBERCULOSIS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 16, no. 7, July 2023, pp. 177-9, doi:10.22159/ajpcr.2023.v16i7.48398.

Issue

Section

Original Article(s)